NCT07100210
- Conditions
- Interleukin, Refractory Malignant Solid Tumors, mRNA Vaccine
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Clinical trial condition
Refractory Malignant Solid Tumors
Explore clinical trials studying Refractory Malignant Solid Tumors. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Refractory Malignant Solid Tumors trial results
Completed
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
NCT07040943
- Conditions
- Interleukin, Refractory Malignant Solid Tumors, mRNA Vaccine
- Locations
-
- Department of Radiation Oncology Chengdu, Sichuan, China
- West China Hospital of Sichuan University Chengdu, Sichuan, China